Clinical Trial

A New Approach to Hemiplegic Shoulder Pain; Pericapsular Nerve Group Block

Completed
View on ClinicalTrials.gov →
Summary
Hemiplegic shoulder pain (HSP) is a common and clinically significant complication after stroke that negatively affects rehabilitation outcomes. It is associated with shoulder subluxation, capsular contracture, spasticity, and central pain mechanisms, leading to pain, limited range of motion, and reduced quality of life. The suprascapular nerve (SSN) block has been shown to be effective for shoulder pain management; however, the glenohumeral joint (GHJ) receives innervation from multiple nerves including the axillary, subscapular, and lateral pectoral nerves. The recently described pericapsular/periarticular nerve group (PENG) block targets these articular branches and may provide analgesia with minimal motor impairment. This study aims to evaluate the effects of ultrasound-guided PENG block in patients with post-stroke hemiplegic shoulder pain, focusing on pain intensity, range of motion, and quality of life outcomes.
Protocol Amendment History 3 changes
critical Completed without a posted recruiting period 2026-07-30
notable Primary completion pushed: 2026-02-20 -> 2026-06-01 2026-07-30
minor Completion pushed: 2026-03-20 -> 2026-06-01 2026-07-30
Trial Details
NCT Number NCT07302711
Lead Sponsor Marmara University
Conditions Shoulder Pain, Hemiplegia
Enrollment 15 participants
Start Date 2025-11-01
Primary Completion 2026-06-01 (estimated)
Study Completion 2026-06-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-29